BGI Genomics Co., Ltd.

SZSE:300676.SZ

46.6 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012
Revenue 3,866.9214,349.6377,046.1326,766.1378,397.232,800.4122,536.4062,095.5441,711.4981,318.7041,131.9821,047.381794.839
Cost of Revenue 2,263.2252,179.0313,357.1012,835.4233,353.0461,300.5451,132.558902.204711.249586.203612.138463.341415.359
Gross Profit 1,603.6962,170.6073,689.0313,930.7155,044.1841,499.8671,403.8481,193.341,000.25732.5519.844584.039379.481
Gross Profit Ratio 0.4150.4990.5240.5810.6010.5360.5530.5690.5840.5550.4590.5580.477
Reseach & Development Expenses 606.175528.925535.786487.148619.642317.315260.92174.314176.724101.764130.63650.59539.915
General & Administrative Expenses 129.617128.58140.85156.787126.24872.5955.65850.21668.81143.37537.674137.948106.074
Selling & Marketing Expenses 567.321549.6861,608.6681,238.3111,078.444618.737514.276401.861327.612240.551213.92220.852136.124
SG&A 696.9371,507.2121,749.5181,395.0981,204.692691.327569.934452.077396.423283.927251.594358.8242.198
Other Expenses 1,175.352-13.588151.731200.85406.67187.512-3.501-7.37429.01425.96522.1916.0061.92
Operating Expenses 2,478.4642,019.9582,437.0352,083.0962,231.0061,096.154911.004708.494673.087467.182457.46365.387253.858
Operating Income -874.768150.6491,659.1871,822.8352,498.174330.129478.416503.508382.343303.90853.56199.022104.382
Operating Income Ratio -0.2260.0350.2350.2690.2970.1180.1890.240.2230.230.0470.190.131
Total Other Income Expenses Net -11.347-35.114-379.029-188.626-55.88-1.943-3.501-8.00228.96720.28221.417-13.991-19.401
Income Before Tax -886.115115.5361,006.9571,745.8932,442.294328.185474.916496.133409.687324.1974.909204.661106.221
Income Before Tax Ratio -0.2290.0270.1430.2580.2910.1170.1870.2370.2390.2460.0660.1950.134
Income Tax Expense 25.98621.854197.515268.195340.24249.66667.07272.44759.6752.13516.3831.99320.867
Net Income -902.69192.9802.7651,461.5362,090.285276.334386.646398.092332.691262.128.121135.88181.734
Net Income Ratio -0.2330.0210.1140.2160.2490.0990.1520.190.1940.1990.0250.130.103
EPS -2.190.231.963.565.250.690.971.050.920.770.111.661.32
EPS Diluted -2.190.231.963.555.240.690.971.050.920.770.111.661.32
EBITDA -350.567643.9321,560.6222,139.4742,762.508600.68671.97636.584527.551432.78180.469259.657145.124
EBITDA Ratio -0.0910.1480.2210.3160.3290.2140.2650.3040.3080.3280.1590.2480.183